Miyakogusa Predicted Gene

Lj6g3v1417030.4

BLASTP 2.2.25 [Feb-01-2011]


Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer, 
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997), 
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs",  Nucleic Acids Res. 25:3389-3402.

Reference for compositional score matrix adjustment: Altschul, Stephen F., 
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.

Query= Lj6g3v1417030.4 Non Characterized Hit- tr|I1F931|I1F931_AMPQE
Uncharacterized protein (Fragment) OS=Amphimedon
queen,28.9,0.00000000004,YqaJ,YqaJ viral recombinase; Restriction
endonuclease-like,Restriction endonuclease  type II--like;
,CUFF.59470.4
         (319 letters)

Database: Medicago_aa4.0v1 
           62,319 sequences; 21,947,249 total letters

Searching..................................................done



                                                                 Score    E
Sequences producing significant alignments:                      (bits) Value

Medtr2g437670.1 | type II superfamily restriction endonuclease |...   474   e-134
Medtr2g088950.1 | type II superfamily restriction endonuclease |...   469   e-132
Medtr2g088950.4 | type II superfamily restriction endonuclease |...   469   e-132
Medtr2g088950.3 | type II superfamily restriction endonuclease |...   469   e-132
Medtr2g088950.2 | type II superfamily restriction endonuclease |...   469   e-132
Medtr2g088950.5 | type II superfamily restriction endonuclease |...   469   e-132
Medtr8g080020.1 | type II-like restriction endonuclease, putativ...   181   6e-46

>Medtr2g437670.1 | type II superfamily restriction endonuclease | HC
           | chr2:14845430-14843379 | 20130731
          Length = 344

 Score =  474 bits (1219), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 231/320 (72%), Positives = 258/320 (80%), Gaps = 8/320 (2%)

Query: 8   EIAPSLSVVCLQCFLRRS-----GLVGCLGHKRNFRSNTSMHASNNPSRRSGSVDSLLKY 62
           +I  SLSV C+Q F   S      LV CL +KR F SN S HA +NPS+R G+   +LK+
Sbjct: 25  KIGSSLSVACVQHFKHESSYYKGALVACLSNKRIFSSNASSHAPDNPSKRFGNGGGMLKF 84

Query: 63  TSSETYPVLQASSLQHWFKNWQELRKYKLTASTFAGAIGFWPRRRVQLWLEKIGAIEPFH 122
           TS ET+ VL+A  LQHWFKNWQ LRK KLTASTFA AIGFW +RR QLWLEKIGAIEPF 
Sbjct: 85  TSEETHSVLEAPCLQHWFKNWQTLRKQKLTASTFAAAIGFWHKRRSQLWLEKIGAIEPFS 144

Query: 123 GNLATCWSNIKEEEALERYKLITGNTVLFPEFQVYSVKPEDDWLAASPDGVV---VYELP 179
           GNLATCWSNIKEEEALERYKLIT NTVLF EFQVY  KPED WLAASPDG++   VY+LP
Sbjct: 145 GNLATCWSNIKEEEALERYKLITVNTVLFSEFQVYDSKPEDSWLAASPDGIIDRMVYDLP 204

Query: 180 SSGVLEIKCPYFNGDKNKAFPWSRIPLYCIPQAQGLMEILGTDWMDFYVWTLNGSSLFRL 239
           S GVLE+KCPYF GD +KA PW RIP++ IPQAQGLMEILG DWMDFYVWT+NGSSLFR+
Sbjct: 205 SRGVLEVKCPYFVGDMSKALPWYRIPVHYIPQAQGLMEILGRDWMDFYVWTVNGSSLFRI 264

Query: 240 YRDAEYWDVMKTALSDFWLNHVLPARELYSSNVITDPLYQLRSLRPAPRHELCSYIVYKS 299
           YRD EYWDVMK ALSDFW  HV PARE YSS+VI DPL+QLRSL PAP+HELC  IVY+S
Sbjct: 265 YRDPEYWDVMKIALSDFWWKHVQPARESYSSSVIKDPLFQLRSLTPAPKHELCRDIVYRS 324

Query: 300 KHIVDNSQLLMREFNGKLQN 319
           KHIVDNS LL+RE +GK+ N
Sbjct: 325 KHIVDNSNLLIREIHGKMTN 344


>Medtr2g088950.1 | type II superfamily restriction endonuclease | HC
           | chr2:37519145-37517464 | 20130731
          Length = 344

 Score =  469 bits (1208), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 229/320 (71%), Positives = 257/320 (80%), Gaps = 8/320 (2%)

Query: 8   EIAPSLSVVCLQCFLR-----RSGLVGCLGHKRNFRSNTSMHASNNPSRRSGSVDSLLKY 62
           +I  SLSV  +Q F       +  LV CL +KR F SN S HA +NPS+R G+   +LK+
Sbjct: 25  KIGSSLSVARVQHFKHGSSYYKGALVACLSNKRIFSSNASSHAPDNPSKRFGNGGGMLKF 84

Query: 63  TSSETYPVLQASSLQHWFKNWQELRKYKLTASTFAGAIGFWPRRRVQLWLEKIGAIEPFH 122
           TS ET+ VL+A  LQHWFKNWQ LRK KLTASTFA AIGFW +RR QLWLEKIGAIEPF 
Sbjct: 85  TSEETHSVLEAPCLQHWFKNWQTLRKQKLTASTFAAAIGFWHKRRSQLWLEKIGAIEPFS 144

Query: 123 GNLATCWSNIKEEEALERYKLITGNTVLFPEFQVYSVKPEDDWLAASPDGVV---VYELP 179
           GNLATCWSNIKEEEALERYKLIT NTVLF EFQVY  KPED WLAASPDG++   VY+LP
Sbjct: 145 GNLATCWSNIKEEEALERYKLITENTVLFSEFQVYDSKPEDSWLAASPDGIIDRMVYDLP 204

Query: 180 SSGVLEIKCPYFNGDKNKAFPWSRIPLYCIPQAQGLMEILGTDWMDFYVWTLNGSSLFRL 239
           S GVLE+KCPYF GD +KA PW RIP++ IPQAQGLMEILG DWMDFYVWT+NGSSLFR+
Sbjct: 205 SRGVLEVKCPYFGGDMSKALPWYRIPVHYIPQAQGLMEILGRDWMDFYVWTVNGSSLFRI 264

Query: 240 YRDAEYWDVMKTALSDFWLNHVLPARELYSSNVITDPLYQLRSLRPAPRHELCSYIVYKS 299
           YRD EYWDVMK ALSDFW  HV PARE YSS+VI DPL+QLRSL PAP+HELC  IVY+S
Sbjct: 265 YRDPEYWDVMKIALSDFWWKHVQPARESYSSSVIKDPLFQLRSLTPAPKHELCRDIVYRS 324

Query: 300 KHIVDNSQLLMREFNGKLQN 319
           KHIVDNS LL+RE +GK+ N
Sbjct: 325 KHIVDNSNLLIREIHGKMTN 344


>Medtr2g088950.4 | type II superfamily restriction endonuclease | HC
           | chr2:37519145-37517464 | 20130731
          Length = 344

 Score =  469 bits (1208), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 229/320 (71%), Positives = 257/320 (80%), Gaps = 8/320 (2%)

Query: 8   EIAPSLSVVCLQCFLR-----RSGLVGCLGHKRNFRSNTSMHASNNPSRRSGSVDSLLKY 62
           +I  SLSV  +Q F       +  LV CL +KR F SN S HA +NPS+R G+   +LK+
Sbjct: 25  KIGSSLSVARVQHFKHGSSYYKGALVACLSNKRIFSSNASSHAPDNPSKRFGNGGGMLKF 84

Query: 63  TSSETYPVLQASSLQHWFKNWQELRKYKLTASTFAGAIGFWPRRRVQLWLEKIGAIEPFH 122
           TS ET+ VL+A  LQHWFKNWQ LRK KLTASTFA AIGFW +RR QLWLEKIGAIEPF 
Sbjct: 85  TSEETHSVLEAPCLQHWFKNWQTLRKQKLTASTFAAAIGFWHKRRSQLWLEKIGAIEPFS 144

Query: 123 GNLATCWSNIKEEEALERYKLITGNTVLFPEFQVYSVKPEDDWLAASPDGVV---VYELP 179
           GNLATCWSNIKEEEALERYKLIT NTVLF EFQVY  KPED WLAASPDG++   VY+LP
Sbjct: 145 GNLATCWSNIKEEEALERYKLITENTVLFSEFQVYDSKPEDSWLAASPDGIIDRMVYDLP 204

Query: 180 SSGVLEIKCPYFNGDKNKAFPWSRIPLYCIPQAQGLMEILGTDWMDFYVWTLNGSSLFRL 239
           S GVLE+KCPYF GD +KA PW RIP++ IPQAQGLMEILG DWMDFYVWT+NGSSLFR+
Sbjct: 205 SRGVLEVKCPYFGGDMSKALPWYRIPVHYIPQAQGLMEILGRDWMDFYVWTVNGSSLFRI 264

Query: 240 YRDAEYWDVMKTALSDFWLNHVLPARELYSSNVITDPLYQLRSLRPAPRHELCSYIVYKS 299
           YRD EYWDVMK ALSDFW  HV PARE YSS+VI DPL+QLRSL PAP+HELC  IVY+S
Sbjct: 265 YRDPEYWDVMKIALSDFWWKHVQPARESYSSSVIKDPLFQLRSLTPAPKHELCRDIVYRS 324

Query: 300 KHIVDNSQLLMREFNGKLQN 319
           KHIVDNS LL+RE +GK+ N
Sbjct: 325 KHIVDNSNLLIREIHGKMTN 344


>Medtr2g088950.3 | type II superfamily restriction endonuclease | HC
           | chr2:37519145-37517464 | 20130731
          Length = 344

 Score =  469 bits (1208), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 229/320 (71%), Positives = 257/320 (80%), Gaps = 8/320 (2%)

Query: 8   EIAPSLSVVCLQCFLR-----RSGLVGCLGHKRNFRSNTSMHASNNPSRRSGSVDSLLKY 62
           +I  SLSV  +Q F       +  LV CL +KR F SN S HA +NPS+R G+   +LK+
Sbjct: 25  KIGSSLSVARVQHFKHGSSYYKGALVACLSNKRIFSSNASSHAPDNPSKRFGNGGGMLKF 84

Query: 63  TSSETYPVLQASSLQHWFKNWQELRKYKLTASTFAGAIGFWPRRRVQLWLEKIGAIEPFH 122
           TS ET+ VL+A  LQHWFKNWQ LRK KLTASTFA AIGFW +RR QLWLEKIGAIEPF 
Sbjct: 85  TSEETHSVLEAPCLQHWFKNWQTLRKQKLTASTFAAAIGFWHKRRSQLWLEKIGAIEPFS 144

Query: 123 GNLATCWSNIKEEEALERYKLITGNTVLFPEFQVYSVKPEDDWLAASPDGVV---VYELP 179
           GNLATCWSNIKEEEALERYKLIT NTVLF EFQVY  KPED WLAASPDG++   VY+LP
Sbjct: 145 GNLATCWSNIKEEEALERYKLITENTVLFSEFQVYDSKPEDSWLAASPDGIIDRMVYDLP 204

Query: 180 SSGVLEIKCPYFNGDKNKAFPWSRIPLYCIPQAQGLMEILGTDWMDFYVWTLNGSSLFRL 239
           S GVLE+KCPYF GD +KA PW RIP++ IPQAQGLMEILG DWMDFYVWT+NGSSLFR+
Sbjct: 205 SRGVLEVKCPYFGGDMSKALPWYRIPVHYIPQAQGLMEILGRDWMDFYVWTVNGSSLFRI 264

Query: 240 YRDAEYWDVMKTALSDFWLNHVLPARELYSSNVITDPLYQLRSLRPAPRHELCSYIVYKS 299
           YRD EYWDVMK ALSDFW  HV PARE YSS+VI DPL+QLRSL PAP+HELC  IVY+S
Sbjct: 265 YRDPEYWDVMKIALSDFWWKHVQPARESYSSSVIKDPLFQLRSLTPAPKHELCRDIVYRS 324

Query: 300 KHIVDNSQLLMREFNGKLQN 319
           KHIVDNS LL+RE +GK+ N
Sbjct: 325 KHIVDNSNLLIREIHGKMTN 344


>Medtr2g088950.2 | type II superfamily restriction endonuclease | HC
           | chr2:37519145-37517464 | 20130731
          Length = 344

 Score =  469 bits (1208), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 229/320 (71%), Positives = 257/320 (80%), Gaps = 8/320 (2%)

Query: 8   EIAPSLSVVCLQCFLR-----RSGLVGCLGHKRNFRSNTSMHASNNPSRRSGSVDSLLKY 62
           +I  SLSV  +Q F       +  LV CL +KR F SN S HA +NPS+R G+   +LK+
Sbjct: 25  KIGSSLSVARVQHFKHGSSYYKGALVACLSNKRIFSSNASSHAPDNPSKRFGNGGGMLKF 84

Query: 63  TSSETYPVLQASSLQHWFKNWQELRKYKLTASTFAGAIGFWPRRRVQLWLEKIGAIEPFH 122
           TS ET+ VL+A  LQHWFKNWQ LRK KLTASTFA AIGFW +RR QLWLEKIGAIEPF 
Sbjct: 85  TSEETHSVLEAPCLQHWFKNWQTLRKQKLTASTFAAAIGFWHKRRSQLWLEKIGAIEPFS 144

Query: 123 GNLATCWSNIKEEEALERYKLITGNTVLFPEFQVYSVKPEDDWLAASPDGVV---VYELP 179
           GNLATCWSNIKEEEALERYKLIT NTVLF EFQVY  KPED WLAASPDG++   VY+LP
Sbjct: 145 GNLATCWSNIKEEEALERYKLITENTVLFSEFQVYDSKPEDSWLAASPDGIIDRMVYDLP 204

Query: 180 SSGVLEIKCPYFNGDKNKAFPWSRIPLYCIPQAQGLMEILGTDWMDFYVWTLNGSSLFRL 239
           S GVLE+KCPYF GD +KA PW RIP++ IPQAQGLMEILG DWMDFYVWT+NGSSLFR+
Sbjct: 205 SRGVLEVKCPYFGGDMSKALPWYRIPVHYIPQAQGLMEILGRDWMDFYVWTVNGSSLFRI 264

Query: 240 YRDAEYWDVMKTALSDFWLNHVLPARELYSSNVITDPLYQLRSLRPAPRHELCSYIVYKS 299
           YRD EYWDVMK ALSDFW  HV PARE YSS+VI DPL+QLRSL PAP+HELC  IVY+S
Sbjct: 265 YRDPEYWDVMKIALSDFWWKHVQPARESYSSSVIKDPLFQLRSLTPAPKHELCRDIVYRS 324

Query: 300 KHIVDNSQLLMREFNGKLQN 319
           KHIVDNS LL+RE +GK+ N
Sbjct: 325 KHIVDNSNLLIREIHGKMTN 344


>Medtr2g088950.5 | type II superfamily restriction endonuclease | HC
           | chr2:37519145-37517464 | 20130731
          Length = 344

 Score =  469 bits (1208), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 229/320 (71%), Positives = 257/320 (80%), Gaps = 8/320 (2%)

Query: 8   EIAPSLSVVCLQCFLR-----RSGLVGCLGHKRNFRSNTSMHASNNPSRRSGSVDSLLKY 62
           +I  SLSV  +Q F       +  LV CL +KR F SN S HA +NPS+R G+   +LK+
Sbjct: 25  KIGSSLSVARVQHFKHGSSYYKGALVACLSNKRIFSSNASSHAPDNPSKRFGNGGGMLKF 84

Query: 63  TSSETYPVLQASSLQHWFKNWQELRKYKLTASTFAGAIGFWPRRRVQLWLEKIGAIEPFH 122
           TS ET+ VL+A  LQHWFKNWQ LRK KLTASTFA AIGFW +RR QLWLEKIGAIEPF 
Sbjct: 85  TSEETHSVLEAPCLQHWFKNWQTLRKQKLTASTFAAAIGFWHKRRSQLWLEKIGAIEPFS 144

Query: 123 GNLATCWSNIKEEEALERYKLITGNTVLFPEFQVYSVKPEDDWLAASPDGVV---VYELP 179
           GNLATCWSNIKEEEALERYKLIT NTVLF EFQVY  KPED WLAASPDG++   VY+LP
Sbjct: 145 GNLATCWSNIKEEEALERYKLITENTVLFSEFQVYDSKPEDSWLAASPDGIIDRMVYDLP 204

Query: 180 SSGVLEIKCPYFNGDKNKAFPWSRIPLYCIPQAQGLMEILGTDWMDFYVWTLNGSSLFRL 239
           S GVLE+KCPYF GD +KA PW RIP++ IPQAQGLMEILG DWMDFYVWT+NGSSLFR+
Sbjct: 205 SRGVLEVKCPYFGGDMSKALPWYRIPVHYIPQAQGLMEILGRDWMDFYVWTVNGSSLFRI 264

Query: 240 YRDAEYWDVMKTALSDFWLNHVLPARELYSSNVITDPLYQLRSLRPAPRHELCSYIVYKS 299
           YRD EYWDVMK ALSDFW  HV PARE YSS+VI DPL+QLRSL PAP+HELC  IVY+S
Sbjct: 265 YRDPEYWDVMKIALSDFWWKHVQPARESYSSSVIKDPLFQLRSLTPAPKHELCRDIVYRS 324

Query: 300 KHIVDNSQLLMREFNGKLQN 319
           KHIVDNS LL+RE +GK+ N
Sbjct: 325 KHIVDNSNLLIREIHGKMTN 344


>Medtr8g080020.1 | type II-like restriction endonuclease, putative |
           HC | chr8:34360246-34358747 | 20130731
          Length = 312

 Score =  181 bits (460), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 100/244 (40%), Positives = 138/244 (56%), Gaps = 17/244 (6%)

Query: 81  KNWQELRKYKLTASTFAGAIGFWP-RRRVQLWLEKIGA-----IEPFHGNLATCWSNIKE 134
           + W  LRK +LT STF+ A+GFW   RR +LW +K+ A     +E    N A  W  + E
Sbjct: 77  EEWFALRKDRLTTSTFSTALGFWKGSRRAELWHDKVFASDTQIVESVQRN-AMNWGVLNE 135

Query: 135 EEALERYKLITGNTVLFPEFQVYSVKPEDDWLAASPDGVVVYELPSSGVLEIKCPYFNGD 194
             A+E Y  ITG  V    F V+S K   DWL ASPDGV+      +G+LE+KCPY  G 
Sbjct: 136 AVAVENYTKITGREVTSMGFAVHS-KKSYDWLGASPDGVL-----GTGILEVKCPYNKGK 189

Query: 195 KNKAFPWSRIPLYCIPQAQGLMEILGTDWMDFYVWTLNGSSLFRLYRDAEYWDVMKTALS 254
                PW  +P Y +PQ QG MEI+  +W+D Y WT NGS++FR+ R  EYWD++   L 
Sbjct: 190 PETGLPWKTMPFYYMPQVQGQMEIMDFEWVDLYCWTPNGSTIFRVVRSREYWDIIHGILR 249

Query: 255 DFWLNHVLPARELYSSNVITDPLYQLRSLRPAPRHELCSYIVYKSKHIVDNSQLLMREFN 314
           +FW  +V+PARE     ++     Q+ S +PA  H+L    + KS  +   S+LL RE  
Sbjct: 250 EFWWENVIPAREA----LLLGCEEQVESYKPASTHKLTGLAIAKSIKLASESKLLCREIA 305

Query: 315 GKLQ 318
           G ++
Sbjct: 306 GHVE 309